Cardiovascular disease is the number one cause of death among high-income countries and is projected to be the leading cause of death worldwide by 2030.
An international team of researchers reports in the New England Journal of Medicine dramatically transforming aPAP treatment by helping develop a drug that patients can inhale once a day so their body will clear out the pulmonary waste.